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ABSTRACT 
Objective: The objective of this study was to develop, formulate and evaluate the sodium alginate grafted poly (acrylamide-co-acrylic acid/cloisite-
30B/silver nanoparticle hydrogel composites (SA-PAAm-PAAc/C30B/AgNPs) with varying weight percentage (wt %) of cloisite-30B clay for 
paclitaxel targeted delivery and anticancer activity. 
Methods: Polymer hydrogel composites of different wt % of cloisite-30B modified clay dispersed sodium alginate (SA) grafted polyacrylamide-co-
polyacrylic acid were prepared via in situ free radical initiation polymerization reaction technique. In vitro release of paclitaxel (PT) anticancer drug 
and anticancer studies were performed. The formulations were further evaluated for swelling, drug encapsulation, drug delivery, anticancer activity 
study, Fourier transforms infrared spectroscopy (FT-IR), thermogravimetric (TGA), differential scanning calorimeter (DSC) and x-ray diffraction 
(XRD) characterizations. 
Results: FT-IR spectroscopy of various composite hydrogel formulations displayed good compatibility between sodium alginate, polyacrylamide, 
and polyacrylic acid polymers. The thermal study reveals that the formulations with clay (C30B) and AgNPs in hydrogel composites exhibit good 
thermal stability and less % of weight loss (wt. loss) compared to pure formulations. Further, the highest encapsulation efficiency was shown by the 
formulation S0-0+D (72.66±5.92%) and least encapsulation efficiency was shown by S75Ag+D (41.33±3.12%) compared to rest of the formulations and 
S50Ag+D and S75Ag+D samples exhibits relatively slightly higher and sustained cumulative release rate of PT drug at an average rate of 80±9 % within 72 
h and also shows relatively better anticancer activity compared to other formulations. 
Conclusion: Formulations S50Ag+D and S75Ag+Dwere found to be best formulations with a higher cumulative percentage of PT drug release and showed 
better anticancer activity  
Keywords: Sodium alginate, Cloisite-30B, AgNPs, Hydrogel, Paclitaxel, Drug delivery, anticancer, Acrylamide 




The biomaterials research field has broadened in the last three to four 
decades including drug release systems, anticancer examine, 
immunological kits, biosensors and plenty of other biomedical 
applications [1]. Polymer-clay nanocomposites are a class of hybrid 
biomaterial substances composed of natural polymer matrices and 
nanoscale organophilic clay fillers which include cloisite-30B which is 
methyl, tallow, bis-2 hydroxyethyl quaternary ammonium, where tallow 
is 65% C18, 30% C16, and 5% C14. Clay minerals are widely used 
substances in drug products as delivery vehicles [2]. Montmorillonite 
(MMT) can offer the mucoadhesive capability for the nanoparticle to 
cross the gastrointestinal (GI) barrier. MMT is likewise a robust 
detoxifier, which belongs to the structural family of 2:1 phyllosilicate. 
MMT could absorb nutritional toxins, pathogenic bacteria related 
gastrointestinal route, H+ions in acidosis and metabolic toxins including 
steroidal metabolites associated with pregnancy. Hence blending 
chitosan with cloisite-30B (MMT) can enhance the drug releasing and 
anticancer property of the composite hydrogels [3, 4]. 
New technologies depend upon the improvement of recent 
materials, and these might also surely be the aggregate of recognized 
additives. The structural combination of a polymer hydrogel 
network with a nanoparticles (metals, non-metals, metallic oxides, 
and polymeric moieties) holds the promise of presenting advanced 
capability to the composite material with applications in diverse 
fields, such as catalysis, electronics, bio-sensing, drug delivery, nano-
medicine, antibacterial interest and environmental remediation [5]. 
The sodium alginate hydrogels are in large part used because of their 
high biocompatibility. During the last decade, a huge part of the 
investigation in the biomedical discipline has resolved many problems of 
drug delivery vehicles and bioactive macromolecules. Lately, the 
application of alginate hydrogels as scaffolding materials has attracted 
the attention in the field of tissue engineering, wound dressing, drug 
delivery and some other biomedical uses. A lot of reports have 
recommended that some alginate dressings can enhance wound 
recuperation by stimulating monocytes to provide high levels of 
cytokines which include interleukin-6 and tumor necrosis factor-α [6]. 
Formation of these pro-inflammatory cytokines inside the wounded 
tissue is vital for tissue repair mechanisms that in the end result in 
wound healing [7]. Due to this, alginates are frequently used as they 
relatively ease with which they could undergo gelation with divalent 
cations under suitable conditions which are appropriate for bio 
macromolecules and living cells. 
Synthetically varied methods were proposed for the development of 
AgNPs and AgNP-composites by means of incorporating metal ions 
into thin films of titania, sol-gels, polyelectrolyte multilayer films, 
porous polymers, AgNPs doped natural polymers and viscous resins 
loaded with AgNPs, which are noticeably appropriate for biomedical 
applications and drug delivery [8]. In particular, nanosilver (AgNPs) 
based wound dressings have acquired the appreciation for scientific 
applications, however; dermal toxicity is reported [9-11]. Therefore, 
the mixture of a gel system with silver nanoparticles and cloisite-
30B will be a higher desire for the drug delivery and anticancer 
activity in the form as such. 3-dimensional (3D) gel (nano, micro, 
and hydrogel) networks are quite suitable for the in situ synthesis of 
silver nanoparticles (AgNps) than the maximum of the traditional 
non-aqueous or polymer related synthetic processes [8]. 
Paclitaxel (PT) is one of the best wide-spectrum of chemotherapeutic 
marketers in the treatment of the extensive variety of cancers, together 
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with lung, ovarian, and breast cancers. But, its scientific application has 
been restricted due to its poor water solubility. Due to its low water 
solubility, paclitaxel is formulated in an aggregate of cremophor EL and 
dehydrated ethanol (50:50, v/v) a combination called taxol. However, 
taxol has some severe side consequences related to cremophor EL and 
ethanol. Its contemporary medical management uses the adjuvant of 
great facet outcomes and has undesired pharmacokinetics and bio 
distribution. there is, hence, a need for the development of exchange 
drug transport systems of PT to enhance its solubility, permeability and 
balance and further to promote a sustained, controlled and targeted 
delivery in order to increase its therapeutic results and decrease its 
surface properties [12]. 
The aim of this work was to develop a novel drug delivery system 
based on composite gel formation technique and which can be 
commercially exploited for the well-being of the society [13]. 
Further, the effective incorporation of nanosilver particles into the 
polymer clay hydrogel composites network and these hydrogel 
composites are efficiently utilized for in vitro paclitaxel (PT) drug 
delivery and anticancer activity. 
MATERIALS AND METHODS 
Materials 
Sodium alginate (SA), acryl amide (AAm), acrylic acid (AAc), cloisite-
30B (C30B) nanoclay N,N’-methylene bis acryl amide (MBA), as 
cross linking agent, N,N,N',N-tetramethyl ethylene diamine (TEMED) 
as an accelerator, ammonium persulphate (APS) as an initiator, 
silver nitrate (AgNO3) as precursor, sodium borohydride (NaBH4) as 
reducing agent, paclitaxel (PT), as an anticancer drug (a gift sample 
from my research friend working for Thrombosis Cancer Research 
Center, (TCRC) Bangalore, India) etc. obtained from Sigma Aldrich 
Bangalore, India. The chemicals were used as it received without any 
further purification and double distilled water (DDW) was used 
throughout this experiment 
Development of sodium alginate-poly (acrylamide-co-acrylic 
acid/closite-30B) hydrogel composites 
Sodium alginate poly (acryl amide-co-acrylic acid/closite-30B)/ 
silver nano particle (SA-PAAm-PAAc/C30B/AgNPs) composite 
hydrogel are obtained by preparing sodium alginate solution, by 
dissolving 0.15 gm SA in 5 ml (3% wt/vol. ratio wrt polymer) of 
double distilled water in a 100 ml beaker and stirred using magnetic 
stirrer about 30 min., and for this solution 2 ml of each of monomers, 
acryl amide, and acrylic acid solutions were added (1 gm in 2 ml 
distilled water),further100 mg of MBA (100 mg in 5 ml distilled 
water), 500 mg of APS (500 mg in 5 ml of distilled water), 20 mg of 
TEMED (20 mg in 5 ml of distilled water) solutions were added to 
the above SA solution and mixed thoroughly using magnetic stirrer 
(30 min.), for this solution, different weight percentages of MMT clay 
(cloisite-30B nanoclay) were mixed (previously ultrasonicated for 
one hour each wt. % of cloisite-30B nano clay in 15 ml of DDW) and 
finally the respective solutions are kept in air tight capped test tube 
like bottles and kept in hot water bath by maintaining the 
temperature of about 70-80 °C results in the free radical 
polymerization reaction and after completion of the reaction, the 
respective polymer hydrogel composites are formed which are 
further carefully cut into desired shapes and allowed to stay in 
double distilled (DDW) for about 3 d in a container to remove all the 
un-reacted components or excess chemicals. Further, these samples 
were oven dried for 12 h at ambient temperature and will be used 
for the synthesis of silver nanoparticles, swelling studies, drug 
delivery studies anticancer activity and other characterizations. 
Development of SA-g-poly (acrylamide-co-acrylic acid/cloisite 
30B/AgNPs hydrogel composites 
SA-PAAm-PAAc/C30B/AgNPs based hydrogel composites had been 
prepared by incorporating dry hydrogel disks into the double 
distilled water and equilibrated for 4 d. Those gels have been 
transferred to brown shade airtight bottles containing 50 ml of 
aqueous AgNO3 and which is allowed equilibrating for a day. This 
allows the transfer of silver ions from the solution into the hydrogel 
networks through ion exchange process. The silver ions in SA-
PAAm-PAAc/C30B/AgNPs hydrogel composites had been reduced 
through NaBH4 reducing agent within 2 h into silver nanoparticles 
in the network of hydrogel composites. The developed SA-PAAm-
PAAc/C30B/AgNPs hydrogel composites have been named as S0-0, 
S50-0, S0-Ag, S25-Ag, S50-Ag, and S75-Ag and the scheme of reaction variables 
are tabulated in table 1. 
 
Table 1: Composition of SA-g-Poly (acrylamide-co-acrylic acid)/C30B/Ag hydrogel composites 
























1 S0-0 300 mg/10 ml 1g/5 ml 1g/5 ml 0% 100 mg/5 ml 20 mg/5 ml 500 mg/5 ml Nil 
2 S0-Ag 300 mg/10 ml 1g/5m[l 1g/5 ml 0% 100 mg/5 ml 20 mg/5 ml 500 mg/5 ml Ag 
3 S25-Ag 300 mg/10 ml 1g/5 ml 1g/5 ml 25% (75 mg) 100 mg/5 ml 20 mg/5 ml 500 mg/5 ml Ag 
4 S50-0 300 mg/10 ml 1g/5 ml 1g/5 ml 50% (150 mg) 100 mg/5 ml 20 mg/5 ml 500 mg/5 ml Nil 
5 S50-Ag 300 mg/10 ml 1g/5 ml 1g/5 ml 50% (150 mg) 100 mg/5 ml 20 mg/5 ml 500 mg/5 ml Ag 
6 S75-Ag 300 mg/10 ml 1g/5 ml 1g/5 ml 75% (225 mg) 100 mg/5 ml 20 mg/5 ml 500 mg/5 ml Ag 
[SA: Sodium alginate; AAM: Acrylamide; AA: Acrylic acid; C30B: cloisite-30B; MBA: N,N’-methylenebisacrylamide; TEMED: N,N,N’,N’ 
Tetramethylethylenediamine; APS: Ammonium per sulfate; Ag NPs: Ag nanoparticles] 
 
Swelling studies 
The percentage of swelling fraction (% SF) and the percentage of 
equilibrium swelling (% ES) have been calculated as shown in the 
equations 1 and 2 
% Swelling fraction SF = Ws/Wd …………… (1) 




Where Ws and Wd are mass of swollen SA-PAAm-
PAAc/C30B/AgNPs hydrogel composites for a given time t and dried 
hydrogel composites.  
Here, Q is the equilibrium mass of swollen SA-PAAm-PAAc/ 
C30B/AgNPs hydrogel composites. Equilibrium swelling 
experiments on SAPAC30B/AgNPs hydrogel composites have been 
carried out in double distilled water (DDW) at 30 °C (±05 °C). 
Encapsulation efficiency of SA-PAAm-PAAc/C30B/AgNPs 
hydrogel composites 
Paclitaxel becomes encapsulated into SA-PAAm-PAAc/C30B/AgNPs 
hydrogel composites via a swelling equilibrium method. The 
hydrogels disks were immersed in the known concentration of drug 
solution and allowed them to swell for 24 h at 37 °C. The solubility of 
paclitaxel in double distilled water is 13 mg/ml, which is appreciably 
is quite low. However, sodium salts can increase the solubility of 
paclitaxel up to 65 mg/ml. in order to load the high amount of drug 
content into the polymeric network, the gel disks have been 
immersed in a sodium salt of paclitaxel aqueous solution. 
Equilibration technique allows the absorption of paclitaxel by the 
SA-PAAm-PAAc/C30B/AgNPs hydrogel composites and the drug-
loaded formulations are named asS0-0+D, S50-0+D, S0-Ag+D, S25-Ag+D, S50-Ag+D, 
and S75-Ag+D. The loading efficiency of paclitaxel in the SA-PAAm-
PAAc/C30B/AgNPs hydrogel composites were measured using uv-
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visible spectrophotometer (UV-3092, LAB INDIA, India). Paclitaxel-
loaded hydrogel composites were placed in 50 ml of buffer medium 
(pH=7) and stirred vigorously for 48 h to extract paclitaxel from the 
hydrogel composites. The solution became filtered and analyzed by 
means of the uv-visible spectrophotometer at a particular 
wavelength (λ max. =230 nm). Percentage of paclitaxel loading and 
the encapsulation efficiency (EE) of SA-PAAm-PAAc/C30B/AgNPs 
hydrogel composites had been calculated with the aid of the 
subsequent equations 3 and 4, and the ensuing statistics were 
compiled in table2. 
% of Drug loading D =
Weight of the drug adding (g)
 weight of the polymerDrug 
x100 ……… (3) 
% Encapsulation efficiency ES =
Total amount of drug(g)
 the actual amount of drug 
x100. (4) 
In vitro drug release studies 
In vitro, drug release experiments have completed the usage of the 
dissolution system (DS8000, LABINDIA, India) attached with 8 
baskets. Drug release rates have been measured at 37 °C below a 
100rpm velocity. Drug release kinetics was analyzed by plotting the 
% cumulative release (Mt/M∞) v/s time (t). The SA-PAAm-
PAAc/C30B/AgNPs hydrogel composites had been studied in the 
buffer medium at pH=7.2 and pH=2, at the temperatures of 25 °C 
and 37 °C for distinctive formulations. 
FT-IR characterizations 
Fourier transformation infrared (FT-IR) spectroscopy analysis 
performed to corroborate the possibility of interaction between the 
clay, AgNPs, drug and the polymer. % of transmittance of FT-IR 
spectrum vs wave number was measured using Bruker ALPHA 
Spectrophotometer (Ettlinger, Germany) with a resolution of 4 cm−1 
and scanned between the range 4000 and 500 cm−1. 
DSC-TGA studies 
The thermal stability and thermal degradation of formulated 
hydrogels had been characterized by using differential scanning 
calorimetry (DSC) and thermogravimetric (TGA) evaluation (Netzch 
DSC 200 Fs). The samples (~12 mg) were sealed in aluminium pans 
and heated underneath nitrogen by using heating rate of 100 
°C/min., the heat flow being recorded from 300 °C to 800 °C. Indium 
was used as reference material to calibrate the temperature and 
energy scales of the DSC system. 
XRD analysis 
The X-ray powder diffraction (XRD) patterns of prepared hydrogels 
were obtained using X-ray diffractometer (RigakuUltima IV, Japan) 
equipped with Ni filter and Cu Kα (l = 1.54056 Å) radiation source. 
Cytocompatibility assessment through MTT assay study 
The biocompatibility of the prepared SA-PAAm-PAAc/C30B/ 
AgNPshydrogel composite gels has been determined by the following 
popular protocol with mild modifications [14]. In short, HaCaT cells 
and MCF-7 (breast cancer mobile strains) cells were procured from 
NCCS, Pune, India, and the cells have been grown in DMEM medium. 
After 80% confluency, the cells had been trypsinized and 3000 cells 
properly have been seeded in 96 well plates and stored in a CO2 
incubator at 37 °C. Meantime, the hydrogels have been cut into small 
pieces (1x1 cm) and stored in a dialysis bag and both the ends were 
sealed. The dialysis bag was immersed in 20 ml of PBS solution and 
become stored in constant stirring at 100 rpm for 24 h. The leachets 
from the hydrated hydrogels have been diluted serially with the 
DMEM media (0%, 12.5%, 25%, 50%, and 100%) and then 200 ml of 
extract and the diluted solution added in a 96-well plate. For the 
control, 100% media had been used to evaluate most of the dilution. 
The addition of leachets the 96 well plates were sooner or later stored 
in a CO2 incubator at 37 °C. To detect the cell viability MTT 
experimental solution prepared from a stock solution of 5 mg/ml in 
growth medium without FBS to the final concentration of 0.8 mg/ml, 
100 µl of MTT solution become delivered and incubated for 4 h. After 4 
h of incubation, the MTT solution was discarded, and 100 µl of DMSO 
solvent discharged in every well under dark, followed by an incubation 
of 15 min. and the optical density (OD) of the formazan product was 
read at 595 nm in a microplate reader (Perkin Elmer, Waltham, MS, 
USA). 
Statistical analysis 
All the experiments were done in triplicate, and the results were 
expressed in terms of mean±SD and were analyzed statistically by 
one-way analysis of variance [ANOVA] at the level of significance  
RESULTS AND DISCUSSION 
Swelling studies 
It is the measurement of swelling property of swellable hydrogel 
polymer composites. The study is done by immersing equal weights of 
dried hydrogel samples in distilled water at 25 °C for 3 d and 
determining the swelling fraction using the equation (Eqn.-5) [15]. The 
fig. 1 indicates the swelling property of cloisite-30B clay supported 
silver nanoparticles-sodium alginate-g-polyacrylamide/acrylic 
acid/hydrogel composites (SA-PAAm-PAAc/C30B/AgNPs). The graph 
is plotted as % of weight gained (%W g/g) v/s various samples such as 
S0-0, S0-Ag, S25-Ag, S50-0, S50-Ag, and S75-Ag. Swollen hydrogels had been 
treated first with the AgNO3 solution and then with the NaBH4 solution 
as explained in the experimental section. 
The equilibrium swelling ratio (Q) is calculated from the equation: 
[Q] =We/Wd ……….(5) 
In which we are the weight of water within the swollen hydrogel and 
Wd is the dry weight of the hydrogel. 
 
 
Fig. 1: Indicates the swelling property of Cloisite-30B clay 
supported silver nanoparticles-Sodium alginate-g-poly 
Acrylamide/acrylic acid hydrogel composites. The graph is 
plotted as % of weight gained (%Wt g/g) versus various samples 
such as S0-0, S0-Ag, S25-Ag, S50-0, S50-Ag, and S75-Ag. The results were 
expressed as the mean of three observation, mean±SD (n =3) 
 
The swelling ability of the anticancer and carriers for the 
improvement of site-specific delivery of drugs and inorganic 
substances like clay (C30B), AgNPs in composite hydrogels play a 
critical role in the antibacterial interest, anticancer activity, wound 
restoration system, and other biomedical applications. Fig. 1 
illustrates the swelling ability of the S0-0, S0-Ag, S25-Ag, S50-0, S50-Ag, and 
S75-Ag with time t. The order of the swelling capability of hydrogels 
follows S75-Ag>S50-Ag>S25-Ag>S0-Ag>S50-0>S0-0 The S0-Ag, S25-Ag and S50-Ag 
hydrogel composites show the moderate swelling ratio (22 g/g) 
than the S75-Ag hydrogel (37g/g). Lower swelling capacity was shown 
by the samples S0-0 and S50-0 hydrogel composites may be attributed 
to the absence of AgNPs in the SA/AAm/AAc monomers reduces the 
pore sizes in the hydrogels and presence of cloisite-30B may be 
accountable to provide the extra cross-links inside the chain 
networks. The higher crosslinks restrict the water penetration for 
swelling. Apparently, the porous S75-Ag hydrogel composite show 
higher swelling ability due to presence cloisite-30B in combination 
with Ag NPs increases the porosity in their network structures 
because of intermolecular interaction between water molecules in 
clay galleries and the lone pair electrons of–NH2 and–OH groups 
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present in SA-PAAm-PAAc chains. Interestingly this pattern of 
swelling is also reasonable for the presence of AgNPs in 
nanocomposite hydrogels due to the fact once the Ag nanoparticles 
(AgNPs) are shaped in the gel networks; the general porosity of the 
system will increase allowing an extra number of water molecules 
inside the gel [16]. One extra reason for this behavior is that the 
formed nanoparticles (AgNPs) have distinctive sizes with different 
charge surfaces within the gel networks causing absolute 
enlargement of the networks and in addition the presence of greater 
hydrophilic groups of modified clay (C30B) in conjunction with 
AgNPs that allow a large amount of water to get into the hydrogel. As 
the clay content increases, in the presence of AgNPs in the hydrogel 
composites results in slightly improved swelling capacity. 
Encapsulation efficiency of paclitaxel drug 
Hydrogels had been loaded with paclitaxel, an anticancer drug by 
means of swelling equilibrium method. The hydrogels have been 
allowed to swelling in the paclitaxel solution of recognized 
concentration for 24 h at 37 °C. In general solubility of paclitaxel in 
water may be very less (13 mg/ml), but the solubility of paclitaxel 
increases up to 5 mg/ml. in DMSO that allows loading the most 
paclitaxel into the hydrogel matrix, hydrogel disks were immersed 
in aqueous solution; paclitaxel, so the drug solvent become absorbed 
onto the SA-PAAm-PAAc/C30B/AgNPs composite hydrogels. The 
loading performance of paclitaxel in the hydrogel was determined 
by spectrophotometrically. Approximately 0.53 gm of the drug-
loaded hydrogel was placed in 50 ml of buffer solution and stirred 
vigorously for 48 h to extract the drug from the hydrogels, the 
solution becomes filtered and assayed by UV spectrophotometer 
(LAB INDIA, UV-3092) at constant λ max. = 230 nm. The results of % 
paclitaxel loading and encapsulation efficiency have been calculated 
and listed, and as shown in table 2, in which it depends on the 
polymer type and physical nature of the drug (either in solid form or 
in solution form) during processing. 
 
Table 2: Encapsulation efficiency (%) of paclitaxel drug 
S. No. Code Encapsulation efficiency (%) 
1 S0-0+D 72.66±5.92 
2 S0-Ag+D 56.34±3.95 
3 S25-Ag+D 51.44±4.56 
4 S5o-0+D 64.67±4.92 
5 S50-Ag+D 49.67±2.57 
6 S75-Ag+D 41.33±3.12 
 Data were expressed as the mean of three observation, mean±SD (n=3). 
 
The loading efficiencies had been reduced with the presence of clay 
in addition to AgNPs. In case of S0-0+D, the drug encapsulation 
efficiency was 72.66±5.92%. Due to the presence of AgNPs in S0-Ag+D; 
the encapsulation efficiency was decreased to 56.34±3.95%. 
Similarly, due to the presence of clay in S50-0+D (50% clay), the 
encapsulation efficiency was slightly increased to 64.67±4.92%. In 
other samples (S25-Ag+D, S50-Ag+D, S75-Ag+D), the encapsulation 
efficiencies were decreased from 51.44±4.56 to 41.33±3.12% due to 
increase in the concentration of clay. The decreasing tendency may 
be attributed to the crosslinking nature of clay (closite-30B). Indeed, 
closite-30B acts as cross-linking points in the network, which is 
responsible for the increase of crosslinking density of hydrogel 
network as the increase of clay content. The more is cross-linking 
density, the worse the elasticity of the polymer chains [17] which 
can limit the penetration of paclitaxel into hydrogel network, results 
in a decrease of loading capacity of the drug. Similar outcomes were 
additionally observed [18] in the case of chitosan-g-poly (acrylic 
acid) loaded theophylline hydrogels [18]. Additionally, the excess 
clay acts as the filler and prevents paclitaxel enter into the polymeric 
network which is likewise accountable for the decrease of 
encapsulation efficiency (EE). 
In vitro release of paclitaxel from SA-PA hydrogel composites have 
been evaluated in the medium of simulated gastrointestinal fluids 
(buffer medium of pH 2 and 7.2) 
In vitro drug release study 
In vitro release studies of paclitaxel from SA-PAAm-
PAAc/C30B/AgNPs hydrogel composites have been evaluated for 
the stimulated gastro-intestinal fluids (SGF) and the graphs have 
been plotted by plotting percentage of cumulative release versus 
time in hours as shown in fig. 2. 
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Fig. 2: In vitro release of drug paclitaxel from SA-g-Poly (acryl amide-co-acryl acid) cloisite-30B)/AgNPs hydrogel composites, the results 
were expressed as the mean of three observation, mean±SD (n =3) 
 
The paclitaxel dissolution test of SA-PAAm-PAAc/C30B/AgNPs hydrogel 
composites were performed in dissolution device (LABINDIA DS8000) 
with the aid of the paddle technique laid out in USP XXIII. SA-PAAm-
PAAc/C30B/AgNPs hydrogel composites were immersed in the 500 ml 
of dissolution medium (SGF). The content material became centrifuged 
at 100 rpm at 37 °C±0.5 °C ideal sink conditions were maintained in the 
paclitaxel dissolution study period. The stimulation of gastrointestinal 
transit condition was achieved by means of changing the pH of 
dissolution medium at different time periods. Paclitaxel release kinetics 
was analyzed with the aid of the following equation (Eqn.6), plotting the 
cumulative release profile versus time. 
	
	/∞  …………. (6) 
wherein Mt and M∞ are the quantity of drug released via the hydrogel at 
time t and at equilibrium, k is a specific constant of the hydrogel, and n is 
a specific exponent of the mode of transport of the penetrate, the drug 
release from SA-PAAm-PAAc/C30B/Ag NPs hydrogel composites were 
studied in buffer medium of pH 2 and 7.2. The samples have been 
withdrawn from the dissolution medium at different time intervals using 
pipette fitted with a microfilter and the concentration of PT was 
measured by uv-spectrophotometer (LAB INDIA, UV-3092) at constant λ 
max. = 230 nm. The receptor volume was maintained constant changing 
the equivalent amount of stimulated gastro-intestinal fluids (SGF). The 
concentration of paclitaxel inside the samples was calculated primarily 
based on average calibration curves. All the dissolution studies were 
carried out in triplicate.     
In order to determine the potential applications of SA-PAAm-
PAAc/C30B/AgNPs based superabsorbent hydrogel composites 
containing a pharmaceutically active compound (PT), we've got 
investigated the drug paclitaxel release behaviour form this system 
under physiological conditions. The percentage of the released drug 
from the polymeric carriers as a characteristic of time t [19]. The 
concentration of paclitaxel delivered at selected time durations was 
determined by using the standard procedure. The % of drug release 
was plotted against time t and the cumulative release was 
calculated. As can be seen from the graphs when pH of the medium 
was 7.2, the cumulative release rate of paclitaxel from the test 
hydrogels is increased with increase in clay (C30B) content, in 
addition to the presence of AgNps. Also, the slightly fast and higher 
release rate of the drug in the case of S75-Ag+D,(80±9 % within 72 h) in 
which clay content is 75 wt%. This difference in their swelling 
behaviour was responsible for the variation of the drug release rate 
[16, 18]. Indeed; the drug inside the hydrogel will be released as a 
result of the hydrogel composite volume change and interaction 
between the polymer network and the drug. The fractional release of 
the drug is at once proportional to the swelling ratio of the 
hydrogels. This result suggests that the better swelling ratios of the 
hydrogel create larger surface regions to diffuse the drug. And this 
follows the Nonfickian (Anomalous) type of diffusion mechanism. 
However, it is worth to mention that the release mechanism of a 
drug would depend on the selected dosage form, pH, nature of the 
drug, fillers, and polymer used [20]. 
Further, the in vitro release of PT drug from a biodegradable 
hydrogel nanocomposite systems are affected by the characteristics 
of the polymer, cloisite-30B and silver nanoparticles. Controlling the 
release is too controlling the properties affecting release, consisting 
of particle size, size distribution, drug content, properties of polymer 
and surface properties [21]. 
FT-IR analysis 
The FT-IR spectrum of synthesized SA  -PAAm-PAAc/C30B/AgNPs 
hydrogel composites were evaluated, results show that the 
synthesized hydrogel composites displayed good compatibility 
between SA-PAAm-PAAc polymers with significant changes after 
incorporation of cloisite-30B and silver nanoparticles into hydrogel 
network and the corresponding IR peaks as shown in fig. 3. 
 
 
Fig. 3: FT-IR Spectrum of SAPAAmPAAc/C30B/AgNPs hydrogel 
composites 
 
A peak appeared at 3400 cm-1 indicating the presence of hydrogen 
bonding between SA and PAAm-PAAc polymers causing OH/NH2 
stretching [4] 3400 cm-1 in SA-g-PAAm-PAAc and drug-loaded one 
corresponds to the presence of–O-H stretching vibrations of 
hydroxyl group in the SA backbone, more broadening of 3400 cm-1 
stretch truly suggests that intermolecular hydrogen bond formation 
within the SA-g-PAAm-PAAc and drug-loaded SA-g-PAAm-PAAc 
hydrogel composite samples. 
For all samples the absorption peaks of strong broad band 
intensities in the range between the 3349.18 to 3427 cm-1indicates 
the O-H stretch (hydrogen bonded) and the peaks in the range, for 
all samples were at 2920.45 cm-1 to 2932.23 cm-1 shows the strong 
C-H stretching frequencies, further the stretching frequencies for all 
the samples except S 50-Ag in the range between 1658.86 cm-1 to 
1667.49 cm-1, represents C=C variable stretching frequencies, 
whereas the sample S50-Ag shows stretching variable frequencies at 
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higher wavenumber values of 2104.53 cm-1for–C=C-bonds of SA and 
PAAm-PAAc interaction. 
Typically, Hydrogen bond took place among proton donor and 
proton acceptor atoms. The lone pair of electrons–O-of PAAm-PAAC 
should interact with–H atoms of SA and formed intermolecular 
asymmetrical stretching vibrations at 1600 cm-1 in SA showed the 
presence of–COO group. The characteristic peak at 1600-1668 cm-1 
in all the samples was due to amide groups (-CONH2) of PA (>C=O 
stretch) [22] the bands at 2900-2950 cm-1 had been because of–C-H 
stretch of–CH2 groups of PAAm and PAAc polymers. 
Conversion of 1094 and 1030 cm-1 stretching band of SA 
(1012,1044,1114,1042,1020, 1045 cm-1) in to singlet,1041 cm-
1absorption stretch in SA-PAAm-PAAc denotes the formation of 
secondary alcohol (characteristic peak of–CH-OH in cyclic alcohol C-O 
stretch) during the course of grafting,this shift in the direction of lower 
frequency shows weakening of–C-C-and–C-O-bonds [23,24]. 
Stretching vibration at 1456 cm-1 for the C-N group can be observed 
within the FT-IR spectrum of drug loaded and non-drug loaded SA-
PAAm-PAAc hydrogel composites, which did not see in the spectrum 
of pure SA [25]. The intermolecular hydrogen bond provides an extra 
mechanical strength to the grafted polymer, those differences 
supported the successful grafting of acrylamide and acrylic acid on SA. 
The intensity peaks in the range between all the samples except S50-
Ag are 1406.55 cm-1 to 1455.13 cm-1 which indicates–C-H variable 
bending frequencies may be due to the presence of acid groups in SA 
and PAAm-PPAc interactions and modifiers used during the 
modification of cloisite-30B clay. But the sample S50-Ag showing the 
frequency vibrations at 1667.02 cm-1 this is an extraordinary 
behavior of the sample S50-Ag, Again all the samples except S50-Ag and 
S50-AgD (drug loaded) samples exhibits strong stretching frequencies 
in the range of 1011.94 cm-1 to 1118.84 cm-1 may be due to the 
presence of C-O or C-F groups in ethers or in esters two bands or 
more, and also in the frequency range of 1315.57 cm-1 to 1323 cm-1 
except for the samples S50-Ag, S50-AgD (drug loaded) and S75-Ag may be 
due the C-O stretching of acid group present in SA and also may be 
due to C-O in ester group. Further, in the frequency range between 
951 cm-1 to 1045 cm-1attributes C-O stretching except at 951 cm-1 
frequency for =C-H bending vibrations. 
In trendy, there has been no sizable modifications of functional groups 
discovered in all the nanocomposite hydrogels which includes the 
nanofillers (AgNPs and clay mineral-C30B), which shows that the 
structure of the SA-PAAm-PAAc hydrogel composites have not been 
changed inside the carbohydrate region (700–1700 cm−1) by mixing 
with the nanoparticles (AgNPS). But, the intensity of the peaks 
increased in all the SA-PAAm-PAAc/C30B/AgNPs composite hydrogels 
that are presumably because of the Vander Waals forces among AgNPs 
and the SA-PAAm-PAAc polymers [26]. Consequently, there has been 
no change in the intensity of peaks of clay mineral present in the 
composites, which may be because of the formation of weak 
intermolecular hydrogen bond among SA-PAAm-PAAc hydrogels and 
clay mineral particles. Comparable patterns of FT-IR spectroscopic 
results were found in the nanocomposite hydrogels with combined 
use of AgNPs and clay mineral-C30B. Such increase in strength of 
nanocomposite hydrogels has been frequently found with other 
biopolymer-based nanocomposites such as agar/clay mineral [27] and 
agar/AgNPs nanocomposite films [28]. 
Thermogravimetric analysis 
Thermogravimetric analysis (TGA) and differential scanning 
calorimetric analysis (DSC)were carried out within the range of 30-
800 °C at the heating rate of 20 °C/min. in presence of N2 (100 
ml/min.) and the graphs have been plotted weight % and heat flow 
respectively versus temperature in °C as shown in fig. 4, 5, 6.  
The sample, S0-0, exhibits glass transition temperature (Tg) at 75 °C. 
This formulation does not contain cloisite-30B and silver 
nanoparticles. Therefore it is just like, the plain sample of sodium 
alginate–polyacrylamide-poly acrylic acid (SA-PAAm-PAAc) hydrogel. 
The sample S0-Ag, is the sample without clay and with silver 
nanoparticles, similar Tg was observed, as which shown in the case of 
formulation S0-0, so the presence of silver nanoparticles do not 
influence the thermal stability of the sample, but major thermal 
decomposition was observed in the formulations S0-0, S50-0 S50-Ag and 
S75-Ag in the range of 280-300 °C except in the case of S25-Ag, this may be 
caused due to clay-silver nanoparticle composition in the sample, that 
is 25 wt% of cloisite-30B with AgNps may be the best composition to 
show better thermal stability when compared to other samples. 
Fig. 4, 5, 6 shows, the formulations S0-0 and S0-Ag exhibit 4 exothermic 
peaks and 3 endothermic peaks, endotherms may be due to the 
reason that, absorption of moisture by the samples, whereas S25-Ag 
and S50-0 show 3 exothermic peaks and 3 endothermic peaks. S50-Ag 
and S75-Ag show 2 exothermic and 2 endothermic peaks. Among all 
exothermic peaks, major thermal decomposition was observed at 
the temperature range of 270 °C-300 °C. Before that temperature 
range, they exhibit thermal stability and all the samples show 




Fig. 4: TGA and DSC of SA-PAAm-PAAc/C30B/AgNPs hydrogel composites 
Lakshmi et al. 
Int J App Pharm, Vol 10, Issue 3, 2018, 141-150 
147 
 
Fig. 5: TGA of SA-PAAm-PAAc/C30B/AgNPs hydrogel composites 
 
DSC for all the samples S0-0, S25-Ag, S50-0, S50-Ag and S75-Ag which are 
shown in fig. 4, 5, 6 which indicates, except S0-0 and S50-0 samples the 
Tg was slightly decreased because of absence of cloisite-30B, but in 
the presence of clay and AgNps in the samples attributes to decrease 
in the cross-linking density, thus decreases the thermal stability. 
Actually, the presence of clay should increase the Tg. In DSC graph it 
has been observed that the appearance of sharp peaks at the 
temperature range of 280 °C-310 °C may be due to the 
polymorphism and melt, however in the case of S50-0, S50-Ag and S75-Ag 
no such thermal degradation was observed at 390-410 °C, whereas, 
for S0-0, S0-Ag and S25-Ag further mild prevalence of degradation was 
found. In trendy TGA offers data on the thermal stability of the 
hybrid nanocomposites with reference to polymers which include 
SA (sodium alginate), PAAm and PAAc. In the fig. 4, 5, 6. It has been 
observed that all samples of hybrid hydrogel nanocomposites have 4 
different decomposition steps and 95% thermal degradation of 
hydrogel chains took place at 800 °C, however, it is cited as four 
degradation steps (multi-step degradation). the first major step 
starts around 150 °C which suggests that weight reduction due to 
the evaporation of water molecules and second predominant step 
starts from 350 °C with 90% weight loss were occurred even at 500 
°C for all the samples, except S0-Ag and (two minor steps, negligible 




Fig. 6: DSC of SA-PAAm-PAAc/C30B/AgNPs hydrogel composites 
 
In the case of S0-Ag, 90% of weight loss was observed below 370 °C. 
The difference in decomposition between the pure hydrogel and S0-Ag 
and cloisite-30B/AgNPs nanocomposite hydrogels are found in 
between 20-25% and it confirms that the presence of AgNPs and 
cloisite-30B clay in the hydrogels, as the percentage of clay (cloisite-
30B), increases along with the presence of AgNps which increases 
the difference in weight loss and it will likely to be in very large. In 
present study cloisite-30B and AgNPs in aggregate play a major role, 
in the decrease of thermal degradation of hydrogel composites and 
also which reduces the % of weight loss [29]. The difference in 
weight loss, in comparison to the formulation S0-0, has larger 
difference in wt. loss and lesser will be the thermal stability of the 
sample, further S75-Ag has a larger difference of wt. loss (33%) when 
compared to S0-0 formulation (larger the difference, more stable will 
be the sample) S75-Ag has the difference of wt. loss with respect to S0-0 
is 27.5 %, S50-Ag-24.16%, S50-0-23.57 %, S25-Ag-12.23% and S0-Ag-
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10.95%. This data indicates that the formulation S75-Ag is more 
thermally stable compared to all other samples and S0-Ag is least 
thermally stable when compared to the rest, lower the difference, 
lesser will be the thermal stability and larger the difference (in 
terms of wt. loss), higher will be the thermal stability of the 
formulations. 
XRD analysis 
X-ray spectroscopy of various formulations as shown in the fig. 7. 
XRD analysis of SA-PAAm- PAAc/C30B/AgNPs hydrogel composites 
indicate the decrease in crystallinity of pure SA was because of 
formation of new polymer system (SA-PAAm-PAAc) 
 
 
Fig. 7: XRD of SA-PAAm-PAAc/C30B/AgNPs hydrogel composites. XRD lines a), b), c),d) indicates intensity peaks for the formulations S0-0, 
S0-Ag, S50-0 and S50-Ag respectively 
 
XRD of SA exhibiting characteristic peaks at 19 °, 28 °, 28.9 °, 32.5 ° 
and 33.5 ° 2θ, while in the case of SA-PAAm-PAAc hydrogels no such 
sharp peaks had been observed, suggesting the complete 
transformation of SA into SA-PAAm-PAAc new polymer hydrogels. 
The FTIR spectrum additionally supported the grafting of PAAm and 
PAAc on to SA and within the drug-loaded gels, Addition of extra 
bulky groups, i.e. polyacrylamide (PAAm) and polyacrylic acid 
(PAAc) on to the backbone of SA may reduce the overall crystallinity 
and also decrease the intermolecular hydrogen bond [26].5 ° and 
19.79 ° of cloisite-30B corresponding to planes (001) and (020) 
respectively, confirming the predominance of cloisite-30B in the 
samples. This suggests that increased interlayer spacing (basal) of 
organic-clays based on the way in which it is guided between the 
lamellae of clay minerals [30]. 
Anticancer study 
The cytotoxicity of extracts from hydrogel composites on HaCaT 
cells was determined by the MTT assay [31]. In the present 
investigation, the cytocompatibility of the obtained hydrogel 
composites was examined in regular epithelial HaCaT cellular 
strains. Fig. 8, 9 depicts the relative proliferation rate of the two 
cellular lines while assessed through MTT assay. NAD (P) H-
dependent cell oxidoreductase enzyme inside the mitochondria has 
the capability to reduce the MTT dye (3-(4, 5-dimethylthiazol-2-yl)-
2, 5-diphenyl tetrazolium bromide) to insoluble formazan [32]. 
The formation of formazan depends upon the rate of cellular 
metabolism, so the cells treated with the different leachant 
percentage should theoretically have the normal rate of metabolism. 
This indicates that the gels had been cytocompatible in nature. No 
visual difference became located inside the cellular morphology, 
suggesting the absence of the unfavorable impact of the leachants on 
mobile proliferation. 
As a substitute, the prepared formulations supported the growth of 
HaCaT cell line to a certain level in comparison to the control. Again 
the cell viability decreases with the increase in clay % as well as in 
the presence of Ag nanoparticles in the gel composites, especially 
the formulations S50-Ag+D, S75-Ag+D show better anticancer activity than 
rest of others (in MCF-7 cell lines). Finally, the biosynthesized AgNPs 
of C30B clay based hydrogel composites shows significant 
anticancer activity, and thus, it can be used as a potential source for 
various biomedical applications [33]. 
 
 
Fig. 8: Cell viability of S0-0, S50-0. The MTT assay was used to measure the viability of HaCaT cells at various dilute extract solution 
concentrations. Media at 100% was used as a control. The results were expressed as the mean of three observation, mean±SD (n =3) 
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Fig. 9: Cell viability of S0-0, S50-0, S0-0+D, S50-0+D, S0-Ag+D, S25-Ag+D, S50-Ag+D, S75-Ag+D. The MTT assay was used to measure the viability of MCF-7 cells 
at various dilute extract solution concentrations. Media at 100% was used as a control. The results were expressed as the mean of three 
observations, mean±SD (n =3) 
 
CONCLUSION 
Hydrogel composites of sodium alginate grafted PAAm-PAAc/ 
C30B/Ag was prepared by free radical polymerization method and 
AgNPs have been successfully incorporated into them by chemical 
reduction method and used to produce sustained delivery of paclitaxel 
for the treatment of cancer. In vitro release studies suggest that co-
grafting of SA with PAAm-PAAc/C30B/AgNPs could be a useful tool for 
the sustaining the delivery of drugs within the stomach. Swelling, FT-
IR, XRD analysis, and DSC--TGA has suggested the successful grafting 
(basically attachment of amide bond of polyacrylamide with the 
carboxyl group of SA) of PAAmPAAc. DSC and XRD data reveal the 
dispersion and amorphization of crystalline Ag, drug, and C30B within 
the matrix of SA-PAAm-PAAc/C30B/AgNPs hydrogel composites. The 
samples S75-Ag, S50-Ag exhibits profound swelling capacity than the rest 
of the other samples due to the simultaneous presence of C30B and 
AgNPs with the increase in % wt of C30B in the respective samples. In 
vitro drug release confirmed the release up to 72 h at the rate of 80±9 
%, whereas gels were able to float up to 85 h. The increase of the 
percentage of grafting, as well as decrease in the amount of C30B, 
could reduce the release rate of the drug; however, it increases the 
drug loading within the SA-g-PAAm-PAAc grafted gastro-retentive 
polymer composite hydrogels. The swelling of grafted SA-g-PAAm-
PAAchydrogel network is strongly interdependent on the cross-linking 
and polymerization process. The drug release depends upon the 
extent of gelation which was based on cross-linking and amount of 
graft copolymer used. This study could prove to be a platform to 
explore the possibility of grafting technology for the preparation of 
gastro retentive hydrogel-based drug delivery systems. The 
formulations S75-Ag, S50-Ag, andS25-Ag shows better anticancer activity and 
slightly higher rate of sustained drug delivery than the rest of other 
(samples without AgNPs and C30B) 
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